AVJennings Limited (SGX:A05)

Market Cap	310.46M
Revenue (ttm)	279.28M
Net Income (ttm)	550.66K
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	563.79
Forward PE	n/a
Dividend	0.14 (21.55%)
Ex-Dividend Date	Jul 28, 2025

Volume	n/a
Average Volume	1,740
Open	0.6500
Previous Close	0.6500
Day's Range	0.6500 - 0.6500
52-Week Range	0.2500 - 0.7000
Beta	n/a
RSI	61.66
Earnings Date	Aug 28, 2025

About Checkpoint Therapeutics

AVJennings Limited engages in the development of residential properties in Australia and New Zealand. It operates through Jurisdictions and Other segments. The company develops and sells lands, apartments, and housing, such as new homes and townhomes. The company was founded in 1932 and is based in Hawthorn, Australia. AVJennings Limited operates as a subsidiary of SC Global Developments Pte. Ltd.

• Industry: General Building Contractors-residential
• Founded: 1932
• Country: Australia
• Stock Exchange: Singapore Exchange
• Ticker Symbol: A05

Financial Performance

In 2024, AVJennings's revenue was 319.75 million, an increase of 11.83% compared to the previous year's 285.93 million. Earnings were 1.02 million, a decrease of -95.75%.